These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 211499)

  • 21. The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers.
    Pak CY; Nicar M; Northcutt C
    Contrib Nephrol; 1982; 33():136-51. PubMed ID: 6749417
    [No Abstract]   [Full Text] [Related]  

  • 22. Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose, phosphate and thiazides.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():239-52. PubMed ID: 6938001
    [No Abstract]   [Full Text] [Related]  

  • 23. Nephrolithiasis: recent advances in therapy.
    Erwin DT
    South Med J; 1976 Jul; 69(7):935-7. PubMed ID: 941065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symposium on renal lithiasis. Renal lithiasis in review.
    Finlayson B
    Urol Clin North Am; 1974 Jun; 1(2):181-212. PubMed ID: 4372765
    [No Abstract]   [Full Text] [Related]  

  • 25. [Recent progress in therapy of urinary calculi].
    Yatake T
    Hokkaido Igaku Zasshi; 1987 May; 62(3):362-5. PubMed ID: 3301611
    [No Abstract]   [Full Text] [Related]  

  • 26. The causes and medical treatment of renal calculi.
    Rose GA
    Practitioner; 1977 Jan; 218(1303):74-80. PubMed ID: 13357
    [No Abstract]   [Full Text] [Related]  

  • 27. Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment.
    Hallson PC; Rose GA
    Br J Urol; 1976; 48(7):515-24. PubMed ID: 13904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The spectrum and pathogenesis of hypercalciuria.
    Pak CY
    Urol Clin North Am; 1981 Jun; 8(2):245-52. PubMed ID: 7268959
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary oxalate in summer and winter in normal subjects and in stone-forming patients with idiopathic hypercalciuria, both untreated and treated with thiazide and/or cellulose phosphate.
    Hallson PC; Kasidas GP; Rose GA
    Urol Res; 1976; 4(4):169-73. PubMed ID: 1020068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 31. [Possibilities of pharmacological prevention of oxalate calculi].
    Terhorst B; Lutzeyer W
    Z Urol Nephrol; 1972 Nov; 65(11):815-25. PubMed ID: 4665913
    [No Abstract]   [Full Text] [Related]  

  • 32. Rational therapy of nephrolithiasis, Part II.
    Pak CY
    Ration Drug Ther; 1984 Dec; 18(12):1-7. PubMed ID: 6536978
    [No Abstract]   [Full Text] [Related]  

  • 33. Is selective therapy of recurrent nephrolithiasis possible?
    Pak CY; Peters P; Hurt G; Kadesky M; Fine M; Reisman D; Splann F; Caramela C; Freeman A; Britton F; Sakhaee K; Breslau NA
    Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.
    Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP
    Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic hypercalciuria in calcium nephrolithiasis.
    Coe FL; Favus MJ
    Dis Mon; 1980 Sep; 26(12):1-36. PubMed ID: 6905773
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dietary and drug treatments of calcium nephrolithiasis (author's transl)].
    Mirouze J; Monnier L; Granier MP; Borderies A; Gauthier N
    Sem Hop; 1979 Jan 8-15; 55(1-2):7-13. PubMed ID: 34218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of long-term thiazide therapy on calcium and phosphate metabolism in patients with hypercalciuria].
    Kawamura J; Okada Y; Yoshida O; Shigeno C; Morita R; Torizuka K
    Nihon Jinzo Gakkai Shi; 1982 Aug; 24(8):921-8. PubMed ID: 7176187
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical treatment to prevent recurrent calcium urolithiasis. A guide to critical appraisal.
    Churchill DN
    Miner Electrolyte Metab; 1987; 13(4):294-304. PubMed ID: 3627054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.